| Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination N Pardi, MJ Hogan, RS Pelc, H Muramatsu, H Andersen, CR DeMaso, ... Nature 543 (7644), 248-251, 2017 | 972 | 2017 |
| Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys S Santra, HX Liao, R Zhang, M Muldoon, S Watson, W Fischer, J Theiler, ... Nature medicine 16 (3), 324-328, 2010 | 301 | 2010 |
| Immune and genetic correlates of vaccine protection against mucosal infection by SIV in monkeys NL Letvin, SS Rao, DC Montefiori, MS Seaman, Y Sun, SY Lim, WW Yeh, ... Science translational medicine 3 (81), 81ra36-81ra36, 2011 | 213 | 2011 |
| Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge T Bradley, J Pollara, S Santra, N Vandergrift, S Pittala, C Bailey-Kellogg, ... Nature communications 8 (1), 15711, 2017 | 145 | 2017 |
| Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection A Abayasingam, H Balachandran, D Agapiou, M Hammoud, C Rodrigo, ... Cell reports Medicine 2 (4), 2021 | 79 | 2021 |
| Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability DL Burnett, KJL Jackson, DB Langley, A Aggarwal, AO Stella, ... Immunity 54 (12), 2908-2921. e6, 2021 | 55 | 2021 |
| Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib D Dumka, P Puri, N Carayol, C Lumby, H Balachandran, K Schuster, ... Leukemia & lymphoma 50 (12), 2017-2029, 2009 | 55 | 2009 |
| Recombinant Mycobacterium bovis BCG Prime-Recombinant Adenovirus Boost Vaccination in Rhesus Monkeys Elicits Robust Polyfunctional Simian … MJ Cayabyab, B Korioth-Schmitz, Y Sun, A Carville, H Balachandran, ... Journal of virology 83 (11), 5505-5513, 2009 | 55 | 2009 |
| Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens S Santra, M Muldoon, S Watson, A Buzby, H Balachandran, KR Carlson, ... Virology 428 (2), 121-127, 2012 | 54 | 2012 |
| Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys A Rodríguez, R Mintardjo, D Tax, G Gillissen, J Custers, MG Pau, J Klap, ... Vaccine 27 (44), 6226-6233, 2009 | 51 | 2009 |
| Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses H Balachandran, C Phetsouphanh, D Agapiou, A Adhikari, C Rodrigo, ... Cell reports 38 (6), 2022 | 50 | 2022 |
| Comparison of immunogenicity in rhesus macaques of transmitted-founder, HIV-1 group M consensus, and trivalent mosaic envelope vaccines formulated as a DNA prime, NYVAC, and … SL Hulot, B Korber, EE Giorgi, N Vandergrift, KO Saunders, ... Journal of virology 89 (12), 6462-6480, 2015 | 45 | 2015 |
| Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease RC Zahn, MD Rett, M Li, H Tang, B Korioth-Schmitz, H Balachandran, ... Blood, The Journal of the American Society of Hematology 115 (15), 3070-3078, 2010 | 42 | 2010 |
| Immunization with an SIV-based IDLV expressing HIV-1 Env 1086 clade C elicits durable humoral and cellular responses in rhesus macaques D Negri, M Blasi, C LaBranche, R Parks, H Balachandran, M Lifton, ... Molecular Therapy 24 (11), 2021-2032, 2016 | 37 | 2016 |
| SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents P Garcia-Valtanen, CM Hope, MG Masavuli, AEL Yeow, H Balachandran, ... Cell Reports Medicine 3 (6), 2022 | 36 | 2022 |
| Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes M Asmal, C Luedemann, CL Lavine, LV Mach, H Balachandran, ... Virology 475, 37-45, 2015 | 31 | 2015 |
| Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients R Rouet, JY Henry, MD Johansen, M Sobti, H Balachandran, DB Langley, ... Nature communications 14 (1), 687, 2023 | 29 | 2023 |
| Strong, but age-dependent, protection elicited by a deoxyribonucleic acid/modified vaccinia Ankara simian immunodeficiency virus vaccine V Chamcha, S Kannanganat, S Gangadhara, R Nabi, PA Kozlowski, ... Open forum infectious diseases 3 (1), ofw034, 2016 | 21 | 2016 |
| Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge. Nat Commun 8: 15711 T Bradley, J Pollara, S Santra, N Vandergrift, S Pittala, C Bailey-Kellogg, ... | 20 | 2017 |
| Immune and genetic correlates of vaccine protection against mucosal infection by SIV in monkeys. Sci Transl Med 3: 81ra36 NL Letvin, SS Rao, DC Montefiori, MS Seaman, Y Sun, SY Lim, WW Yeh, ... | 19 | 2011 |